Hermann Einsele Selected Research

Hermann Einsele Research Topics

Disease

140	Multiple Myeloma 12/2022 - 05/2003
88	Neoplasms (Cancer) 12/2022 - 04/2005
72	Infections 06/2022 - 02/2000
30	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 05/2003
28	Aspergillosis 02/2022 - 04/2002
25	Hematologic Neoplasms (Hematological Malignancy) 11/2022 - 12/2002
23	Leukemia 04/2020 - 10/2006
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2009
16	Neutropenia 01/2021 - 02/2002
14	Mycoses (Diseases, Fungus) 01/2017 - 05/2002
13	Invasive Fungal Infections 06/2021 - 10/2003
12	Lymphoma (Lymphomas) 10/2022 - 12/2005
12	Communicable Diseases (Infectious Diseases) 02/2020 - 10/2003
11	Disease Progression 01/2022 - 04/2005
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 04/2008
9	Cytomegalovirus Infections (Inclusion Disease) 01/2019 - 02/2002
8	Bronchiolitis Obliterans Syndrome 10/2022 - 04/2011
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 12/2005
7	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2012
7	Residual Neoplasm 01/2022 - 06/2011
7	Virus Diseases (Viral Diseases) 01/2020 - 11/2002
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2022 - 12/2005
6	Bites and Stings (Sting) 01/2022 - 04/2016
6	Thrombocytopenia (Thrombopenia) 01/2021 - 02/2002
6	Cytokine Release Syndrome 01/2020 - 12/2011
5	Inflammation (Inflammations) 06/2019 - 01/2010
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 04/2008
5	Necrosis 02/2017 - 10/2002
5	Fever (Fevers) 12/2015 - 10/2003
5	Rheumatoid Arthritis 04/2014 - 08/2007
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2022 - 03/2016
4	Invasive Pulmonary Aspergillosis 02/2022 - 10/2003
4	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 12/2009
4	Anemia 10/2021 - 01/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2013
4	Pneumonia (Pneumonitis) 01/2021 - 12/2006
4	Lymphopenia (Lymphocytopenia) 01/2021 - 03/2004
4	Melanoma (Melanoma, Malignant) 01/2020 - 02/2012
4	Sepsis (Septicemia) 01/2020 - 10/2003
4	Peripheral Nervous System Diseases (PNS Diseases) 03/2017 - 12/2005
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017 - 02/2008
4	Hypoxia (Hypoxemia) 08/2016 - 07/2007
3	Renal Insufficiency (Renal Failure) 06/2022 - 06/2011
3	COVID-19 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

24	Bortezomib (Velcade)FDA Link 01/2022 - 12/2005
24	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 08/2007
19	Chimeric Antigen ReceptorsIBA 06/2022 - 01/2019
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
19	AntigensIBA 06/2021 - 05/2002
18	Lenalidomide (CC 5013)FDA Link 01/2022 - 02/2008
16	CytokinesIBA 06/2021 - 10/2002
15	Monoclonal AntibodiesIBA 01/2022 - 12/2006
14	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2000
13	Proteasome InhibitorsIBA 01/2022 - 12/2005
12	Biomarkers (Surrogate Marker)IBA 03/2021 - 05/2013
10	Chemokine ReceptorsIBA 11/2022 - 04/2015
10	Pharmaceutical PreparationsIBA 01/2022 - 04/2008
10	Biological ProductsIBA 07/2019 - 01/2010
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 12/2006
9	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 05/2010
8	blinatumomabIBA 01/2020 - 08/2008
7	Immunomodulating AgentsIBA 01/2022 - 01/2015
7	fludarabineIBA 01/2022 - 12/2006
7	AntibodiesIBA 01/2021 - 05/2004
7	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 02/2002
7	PanobinostatIBA 10/2017 - 10/2014
6	daratumumabIBA 01/2022 - 01/2020
6	Thalidomide (Thalomid)FDA Link 01/2021 - 08/2009
6	Dasatinib (BMS 354825)FDA Link 01/2019 - 04/2008
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2011 - 11/2002
5	Immunoglobulins (Immunoglobulin)IBA 12/2022 - 08/2011
5	pomalidomideIBA 01/2022 - 01/2015
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 04/2009
5	carfilzomibIBA 01/2021 - 07/2016
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
5	Phosphotransferases (Kinase)IBA 01/2020 - 10/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 10/2002
5	Rituximab (Mabthera)FDA Link 03/2016 - 12/2006
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2015 - 01/2007
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2015 - 10/2003
4	68Ga-pentixaforIBA 11/2022 - 08/2020
4	Busulfan (Busulfex)FDA Link 01/2022 - 12/2009
4	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 10/2004
4	B-Cell Maturation AntigenIBA 01/2021 - 01/2020
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020 - 01/2017
4	galactomannanIBA 08/2020 - 10/2003
4	ixazomibIBA 01/2020 - 01/2017
4	elotuzumabIBA 01/2020 - 08/2015
4	Fluconazole (Zonal)FDA LinkGeneric 04/2019 - 10/2003
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2015 - 05/2003
3	Surface Antigens (Surface Antigen)IBA 01/2022 - 01/2020

Therapy/Procedure

128	Therapeutics 06/2022 - 02/2000
67	Stem Cell Transplantation 02/2022 - 02/2002
38	Hematopoietic Stem Cell Transplantation 10/2022 - 10/2003
34	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
33	Immunotherapy 01/2022 - 10/2003
31	Transplantation 01/2022 - 08/2000
17	Cell Transplantation 01/2022 - 11/2005
10	Homologous Transplantation 01/2022 - 06/2003
4	Salvage Therapy 04/2022 - 12/2006